Are PCSK9 Inhibitors Cost Effective? [electronic resource]
Producer: 20190923Description: 1031-1041 p. digitalISSN:- 1179-2027
- Anticholesteremic Agents -- economics
- Cost-Benefit Analysis -- statistics & numerical data
- Drug Therapy, Combination -- economics
- Enzyme Inhibitors -- economics
- Ezetimibe -- economics
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- economics
- Hypercholesterolemia -- drug therapy
- PCSK9 Inhibitors
- Quality-Adjusted Life Years
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.